Open Label Assessment of Long-Term Safety and Utility
The purpose of this study is to monitor the long-term analgesic effectiveness, safety, and utility of oxymorphone ER for the relief of moderate to severe pain due to cancer.
Pain
DRUG: Oxymorphone ER
Assessment of AEs and clinical laboratory values, 22 months
Favorable long-term safety profile for oxymorhpone ER in the treatment of moderate to severe pain in patients with cancer, 22 months
The purpose of this study is to monitor the long-term analgesic effectiveness, safety, and utility of oxymorphone ER for the relief of moderate to severe pain due to cancer.